A
Anna R. Damato
Researcher at Washington University in St. Louis
Publications - 8
Citations - 121
Anna R. Damato is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 4 publications receiving 58 citations. Previous affiliations of Anna R. Damato include University of Washington.
Papers
More filters
Journal ArticleDOI
Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience.
Perry G. Ridge,Celeste M. Karch,Simon Hsu,Ivan Arano,Craig C. Teerlink,Mark T. W. Ebbert,Mark T. W. Ebbert,Josue D. Gonzalez Murcia,James M. Farnham,Anna R. Damato,Mariet Allen,Xue Wang,Oscar Harari,Victoria Fernandez,Rita Guerreiro,Jose Bras,John Hardy,Ronald G. Munger,Maria C. Norton,Celeste Sassi,Celeste Sassi,Andrew B. Singleton,Steven G. Younkin,Dennis W. Dickson,Todd E. Golde,Nathan D. Price,Nilufer Ertekin-Taner,Carlos Cruchaga,Alison Goate,Chris Corcoran,JoAnn T. Tschanz,Lisa A. Cannon-Albright,Lisa A. Cannon-Albright,John S. K. Kauwe +33 more
TL;DR: The results suggest that RAB10 could be a promising therapeutic target for AD prevention and can be expanded and adapted to other phenotypes, thus serving as a model for future efforts to identify rare variants for AD and other complex human diseases.
Journal ArticleDOI
Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study.
Anna R. Damato,Jingqin Luo,Ruth Katumba,Grayson Talcott,Joshua B. Rubin,Erik D. Herzog,Jian Campian +6 more
TL;DR: Preliminary evidence for the benefit of TMZ chronotherapy to GBM patient survival is presented, and this impact is more pronounced in MGMT-methylated patients.
Journal ArticleDOI
A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.
Anna R. Damato,Ruth Katumba,Jingqin Luo,Himachandana Atluri,Grayson Talcott,Ashwin Govindan,Emily A. Slat,Katherine N. Weilbaecher,Yu Tao,Jiayi Huang,Omar H. Butt,George Ansstas,Tanner M. Johanns,Milan G. Chheda,Erik D. Herzog,Joshua B. Rubin,Jian Campian +16 more
TL;DR: A retrospective study showing greater anti-tumor efficacy for the morning, relative to the evening, administration of TMZ in patients with glioblastoma and concluding Chronotherapy with TMZ is feasible.
Journal ArticleDOI
Circadian clock synchrony and chronotherapy opportunities in cancer treatment
Anna R. Damato,Erik D. Herzog +1 more
TL;DR: In this article, a review highlights advances and challenges in cancer biology as a function of time of day and highlights the need for personalized medicine should include understanding and accounting for daily rhythms in cancer patients.
Journal ArticleDOI
Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience
Perry G. Ridge,Celeste M. Karch,Simon Hsu,Ivan Arano,Craig C. Teerlink,Mark T. W. Ebbert,Mark T. W. Ebbert,Josue D. Gonzalez Murcia,James M. Farnham,Anna R. Damato,Mariet Allen,Xue Wang,Oscar Harari,Victoria Fernandez,Rita Guerreiro,Jose Bras,John Hardy,Ronald G. Munger,Maria C. Norton,Celeste Sassi,Celeste Sassi,Andrew B. Singleton,Steven G. Younkin,Dennis W. Dickson,Todd E. Golde,Nathan D. Price,Nilufer Ertekin-Taner,Carlos Cruchaga,Alison Goate,Chris Corcoran,JoAnn T. Tschanz,Lisa A. Cannon-Albright,Lisa A. Cannon-Albright,John S. K. Kauwe +33 more
TL;DR: The ‘Alzheimer’s Disease Neuroimaging Initiative’ was erroneously included as ‘ alzheimer's disease neuroimaging Initative’ in the author list of the article.